LOINC
Version 2.67

84872-1Epstein Barr virus nuclear 1 IgG Ab [Presence] in Serum by Rapid immunoassayActive

Part Description

LP128550-3   Epstein Barr virus nuclear 1
Epstein-Barr virus (EBV) is a gamma herpes virus also known as human herpes 4 and occurs only in humans. EBV is prevalent worldwide with over 90% of the adult population infected in their lifetime. The virus is spread mainly through body fluids and particularly through saliva. Symptoms of infection include fatigue, fever, inflamed throat, swollen lymph nodes in the neck, enlarged spleen, swollen liver and rash. EBV becomes dormant post infection but occasionally will reactivate especially in immunosuppressed patients. Laboratory tests are used to determine whether the infection is a primary infection (absence of anti-EBNA, presence of anti-VCA) or a past infection (presence of both anti-EBNA and anti-VCA) Epstein-Barr nuclear antigen begins to appear 2-4 months after symptoms first are evident and persist for the life of the patient. (http://www.cdc.gov/epstein-barr/laboratory-testing.html) Epstein-Barr nuclear antigen 1 (EBNA1) antibody is the main antibody tested in immunoassay tests. It is also the only EBV protein regularly present in EBV-associate neoplasms. There is little difference between EBNA 1 and EBNA 2 other than in their prevalence across the globe. Viral capsid antigen (VCA) p150 antibody is most commonly used in laboratory testing, but VCA p18 is also utilized though some reports of mixed results has been observed.(Manual of Clinical Microbiology, 11th edition, James H. Jorgensen; Karen C. Carroll; Guido Funke; Michael A Pfaller; Marie Louise Landry; Sandra S. Richter; David W. Warnock) Source: Regenstrief LOINC

Fully-Specified Name

Component
Epstein Barr virus nuclear 1 Ab.IgG
Property
PrThr
Time
Pt
System
Ser
Scale
Ord
Method
IA.rapid

Additional Names

Short Name
EBV NA 1 IgG Ser Ql IA.rapid
Display Name
EBV nuclear 1 IgG IA.rapid Ql (S)

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.58
Last Updated
Version 2.65
Change Reason
Corrected Class from SERO to MICRO
Order vs. Observation
Both

Example Answer List LL360-9

Source: Regenstrief Institute

Answer Code Score Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) LA6577-6

Language Variants Get Info

zh-CNChinese (CHINA)
Epstein Barr 病毒细胞核 1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法.快速
nl-NLDutch (NETHERLANDS)
Epstein-Barvirus nuclear 1 As.IgG:aanwezigheid:moment:serum:ordinaal:immunoassay.sneltest
fr-CAFrench (CANADA)
Nucléaire de l'Epstein-Barr 1 , IgG:Présence-Seuil:Temps ponctuel:Sérum:Ordinal:IA.rapide
fr-FRFrench (FRANCE)
Epstein barr virus Ac nucléaire IgG 1:Présence/Seuil:Ponctuel:Sérum:Qualitatif:Immunoanalyse rapide
it-ITItalian (ITALY)
Epstein Barr virus, nucleari 1 , Ab.IgG:PrThr:Pt:Siero:Ord:IA.rapido
ru-RURussian (RUSSIAN FEDERATION)
Эпштейн Барр вирус ядерный 1 Ат.IgG:PrThr:ТчкВрм:Сыв:Пор:IA.rapid
es-ESSpanish (SPAIN)
Virus nuclear de Epstein Barr IgG:PrThr:Punto temporal:Suero:Ord:IA.rapid
tr-TRTurkish (TURKEY)
Epstein Barr virus nükleer 1 Ab.IgG:MevcEşik:Zmlı:Ser:Srl:İA.hızlı

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=84872-1